Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. - Wikidata - awgldk - TriplyDB

Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.

Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.

http://www.wikidata.org/entity/Q45251408

about

Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium Autocrine and paracrine angiopoietin 1/Tie-2 signaling promotes muscle satellite cell self-renewal Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans Overexpression of angiopoietin-1 reduces doxorubicin-induced apoptosis in cardiomyocytes Angiopoietin1 inhibits mast cell activation and protects against anaphylaxis Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.Angiopoietin 2 signaling plays a critical role in neural crest cell migration.Angiogenesis-related factors in skeletal muscles of COPD patients: roles of angiopoietin-2.Angiopoietin-2: development of inhibitors for cancer therapy.Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality.Proinflammatory stem cell signaling in cardiac ischemia Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway Expression and functional roles of angiopoietin-2 in skeletal muscles PlGF repairs myocardial ischemia through mechanisms of angiogenesis, cardioprotection and recruitment of myo-angiogenic competent marrow progenitors COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats.COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model.Angiopoietin-1 peptide QHREDGS promotes osteoblast differentiation, bone matrix deposition and mineralization on biomedical materials.Molecular control of angiopoietin signalling.Genome-wide association study identifies Loci and candidate genes for body composition and meat quality traits in Beijing-You chickens QHREDGS enhances tube formation, metabolism and survival of endothelial cells in collagen-chitosan hydrogels.Primary monocytes regulate endothelial cell survival through secretion of angiopoietin-1 and activation of endothelial Tie2 The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation Angiopoietin-1 enhances skeletal muscle regeneration in mice.Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease.Altered microRNA expression in bovine skeletal muscle with age.Muscle cell derived angiopoietin-1 contributes to both myogenesis and angiogenesis in the ischemic environment.Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection.Molecular signature of a right heart failure program in chronic severe pulmonary hypertension.Angiopoietin-1 improves endothelial progenitor cell-dependent neovascularization in diabetic wounds.Vasculotide, an Angiopoietin-1 mimetic, ameliorates several features of experimental atopic dermatitis-like disease.Contrary effects of the receptor tyrosine kinase inhibitor vandetanib on constitutive and flow-stimulated nitric oxide elaboration in humans Endothelial-cardiomyocyte interactions in cardiac development and repair The dynamic roles of angiopoietins in tumor angiogenesis.Signaling and functions of angiopoietin-1 in vascular protection.Association of serum angiopoietin-1, angiopoietin-2 and angiopoietin-2 to angiopoietin-1 ratio with heart failure in patients with acute myocardial infarction.Gene control of tyrosine kinase TIE2 and vascular manifestations of infections.Integrin binding angiopoietin-1 monomers reduce cardiac hypertrophy Differentiation of human CD14+ monocytes: an experimental investigation of the optimal culture medium and evidence of a lack of differentiation along the endothelial line

P2860

Q24311749-1BEEBDA7-54AA-4C52-AC6D-413F1014E33E Q24313467-3D4E11CD-BE96-42C6-AF93-6201B9B0EDAF Q25255098-9AB1A448-70EC-4A83-8F32-737051A609CA Q28395625-ACF90171-0438-4E43-9E29-56B61EE4AA51 Q28539900-9978A83E-D0FD-4874-9FE9-4DE98C53E7B1 Q30514534-3DC3C2C1-C315-4709-AEFD-03DFBA951BC7 Q30832184-DF45E707-A358-46C8-BFF2-5172F0019691 Q33799894-444F083F-23EB-473B-A491-C5D20A057113 Q33839423-1CF1E567-421C-4178-AF2C-0E35AB8CD78A Q33850993-890916B0-4BB1-4822-AE57-36156B1C57E8 Q33858319-6253B75B-590B-4464-A341-C2B882B34A55 Q33896998-7C967C75-6D12-4AB5-92ED-46D6BEB17B1F Q33988041-EE7C3DC0-8473-492C-87D3-585479CD2D3F Q34039453-1B200C8E-6ACC-44E2-972F-F3B85EC9300F Q34362253-83CD0FB8-FB16-4764-BE01-0B45FCE73076 Q34596705-C5C4DC40-4C3B-412E-B149-E81CACD080B0 Q34609815-67E36A5C-8085-4DC9-A13D-78A7F072B974 Q34660609-BE55626C-41B4-467B-B30C-B181BA2D6790 Q34700123-8C749772-641F-4015-BFF2-84546B1F3FB5 Q34980989-D1640EF3-02CB-4919-9C28-1C13BAFFF5E4 Q35013388-7725E698-C8E8-436D-BB02-90F591716B26 Q35212821-FA04ACC7-FB50-4A7D-BC56-AB2C3CEE8466 Q35275565-474508C5-09C8-40DD-BDD9-DFFA418EFAEF Q35287105-40EA9B11-5E7F-4305-998D-BD827A8F0D92 Q35458362-3A78D99C-DA3C-4F89-89D5-EBECA059065D Q35565047-8EE163B7-C351-4F15-AAA6-E7F73FE73E72 Q35621136-3F5DB636-E994-4761-91FA-E4AC0C3EBCBC Q35885268-78A5202B-F05C-431B-8730-F35E5F33EC2F Q35928926-CCA67E34-D7D8-4C02-9808-02D201517FAB Q35991288-3DF159D0-5B46-4F73-BA14-C88488171244 Q35995364-F10924CE-A0FD-4185-90BD-96263E124235 Q36033171-5E0EDB35-DEA9-41AE-88CC-170B3CFEC821 Q36100725-B8121219-8EC7-4310-96F4-377EA0D8FD59 Q36387870-7655F7D5-82C5-49E1-8E6F-66A2BB8C1855 Q36429528-7A4DCC42-413E-4EA0-B308-9206C74E3EB8 Q36462707-D67B16DB-1E16-4C27-85D8-E75D0773EAA6 Q36603939-E86F5F36-EC8F-483A-93B7-C46DBBF11121 Q36658971-E760C007-8E88-4BFC-B4B3-7F15B7790511 Q36804940-7B57AF63-E6CA-4EC2-A6E4-CB6A20CD5C4D Q36865102-40F003E0-1B40-4D7A-B50C-118505022C80

P2860

Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.

http://www.wikidata.org/entity/Q45251408

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.

@en

Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.

@nl

type

label

Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.

@en

Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.

@nl

prefLabel

Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.

@en

Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.

@nl

P1433

Q45251408-206A1C3C-EBD5-4CEF-BBBB-6523C9E71C9C

P1476

Q45251408-CCE20B12-B4A6-473E-8C72-38B31E63D3BF

P2093

Q45251408-0FA95482-C8BF-46CD-95BE-B1778E888A93

Q45251408-3F4E351A-BF2B-45BF-A960-1B130E5BA40E

Q45251408-4F19862A-DB23-48E4-BEA6-C69A97ACD895

Q45251408-A0DB8126-8D73-42F2-B7CA-3C0970772073

Q45251408-A6997477-B443-4A7B-B920-33CE60F2E428

P304

Q45251408-8E3C356F-4D57-4A12-B0ED-A5A6337DA9A3

P31

Q45251408-12E92488-845C-48F0-89AC-125180B60F74

P356

Q45251408-CE4B783C-B53B-4761-A9C1-823B5E8B3161

P433

Q45251408-BEB9DECC-AC31-4E8D-A446-BAD7F8FF7166

P478

Q45251408-9EFDF358-A8BD-4F33-93F1-5B74A058BF10

P577

Q45251408-0484FF8E-9E62-482E-BE7B-C1F561F1C61C

P698

Q45251408-72527F9F-99E2-4C19-9F75-849C1ADCD9B8

P356

01.RES.0000158285.57191.60

P1433

Circulation Research

P1476

Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.

@en

P2093

Blanca E Himes

http://www.w3.org/2001/XMLSchema#string

Julianne R Oberle

http://www.w3.org/2001/XMLSchema#string

Maria A Rupnick

http://www.w3.org/2001/XMLSchema#string

Nesreen Ismail

http://www.w3.org/2001/XMLSchema#string

Susan M Dallabrida

http://www.w3.org/2001/XMLSchema#string

P304

e8-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.RES.0000158285.57191.60

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15692086

http://www.w3.org/2001/XMLSchema#string